drugset / Trial / NCT01304953

Tropisetron on Postoperative Pain

NCT01304953

Phase 4 Completed 296 enrolled Huazhong University of Science and Technology
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The role of 5-HT3A receptors in nociceptive processing has been demonstrated in several animal models. However, studies in human volunteers have not been reported except for one recent study suggesting that ondansetron could alleviate propofol-induced nociception. Previous studies demonstrated that patients anaesthetized with sevoflurane have more pain than those anaesthetized with propofol. And we further posit that the difference is due to the nociceptive processing induced by the action of 5-HT3A receptors. In this prospective, randomized, double-blind, placebo-controlled study, we assessed the analgesic action of a 5-HT3A receptor antagonist (tropisetron) in women after gynaecological laparoscopy under general anaesthesia maintained with either sevoflurane or propofol.

Timeline

Start
2010-01
Primary completion
2010-11
Completion
2010-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Propofol Small molecule
Comparator Sevoflurane Other / unclassified
Subject Tropisetron Small molecule 2 mg Intravenous
Comparator Remifentanil Small molecule 0.1 ug/kg

Indications